Compare Ford Motor Company (F) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ford Motor Company vs Tango Therapeutics Inc. — how do they compare? Ford Motor Company trades at $12.05 (market cap $48.25B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.75B). The key difference: Ford Motor Company is far larger — about 12.9× Tango Therapeutics Inc.'s market cap, and Ford Motor Company pays a 4.96% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ford Motor Company for 105 Days and Tango Therapeutics Inc. for 0 Days on average.
| F | TNGX | |
|---|---|---|
Market Cap | $48.25B | $3.75B |
Volume | 33,627,673 | 9,619,106 |
Sector | Consumer Cyclical | Health |
52-Week High | $17.44 | $32.90 |
52-Week Low | $11.21 | $7.50 |
Typical Hold Time | 105 Days | 0 Days |
Enterprise Value | $180.21B | $2.77B |
Dividend Yield | 4.96% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ford Motor Company (F) trades at $12.05, up 0.42% on the day, with a mixed technical picture showing bearish moving averages but oversold RSI conditions. Fundamentally, the company reported a net loss of $8.18 billion in 2025 despite $187.27 billion revenue, with negative profit margins and declining sales trends. Recent news highlights supplier disruptions affecting F-150 production and a 6.6% Q3 sales decline, though the company maintains its No. 3 U.S. market position.
Ford faces significant challenges with negative profitability and competitive pressures, though analyst consensus suggests 31% upside to the $15.79 price target. The stock presents a value opportunity given low P/S and P/B ratios, but investors must weigh operational headwinds against the company's strong commercial division and ongoing hybrid vehicle transition.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ford Motor Company
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
